The Las Vegas Medical Marijuana Association is a chamber of commerce organized to promote the medical marijuana industry in Nevada. They have a diverse membership of dispensary owners, production facilities, cultivators, labs and various companies that work
with the industry. They also have patients, doctors, nurses and researchers along with supporters of medical marijuana. They are an inclusive group and believe that we need to include as many people as possible for the health aspects as well as the economic opportunities it will create in Nevada.


With the passage of Recreational Use for marijuana, they are also expanding our scope to assist  industry members with this new market and the new issues which accompany it. They engage with City, County, State entities and the Community to provide information, education and assistance during this time. 

Related News
Please reload


© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: